Gunnar Magnus Modee Persson
Chairman at INITIATOR PHARMA A/S
Net worth: 62 064 $ as of 2024-03-30
Network origin in Gunnar Magnus Modee Persson first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Karolinska Institutet
123
| College/University | Other Consumer Services | 123 |
| Public Company | Pharmaceuticals: Major | 47 | |
22
| Public Company | Biotechnology | 22 |
22
| Public Company | Pharmaceuticals: Major | 22 |
| Public Company | Financial Conglomerates | 15 | |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.
14
| Private Company | Pharmaceuticals: Major | 14 |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland.
14
| Subsidiary | Investment Managers | 14 |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark.
14
| Subsidiary | Pharmaceuticals: Major | 14 |
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden.
10
| Subsidiary | Medical Specialties | 10 |
| Public Company | Pharmaceuticals: Major | 10 | |
| Public Company | Pharmaceuticals: Major | 4 | |
Perma Ventures AB
 Perma Ventures AB Investment ManagersFinance Perma Ventures AB provides financial advisory services. The private company is based in Stockholm, Sweden.
2
| Private Company | Investment Managers | 2 |
Albumedix A/S
 Albumedix A/S Pharmaceuticals: MajorHealth Technology Albumedix A/S is a Danish biotechnology company. The private company is based in Copenhagen, Denmark.
2
| Private Company | Pharmaceuticals: Major | 2 |
Medical Prognosis Institute, Inc.
2
| Subsidiary | 2 | |
ADDI Medical AB
 ADDI Medical AB Packaged SoftwareTechnology Services ADDI Medical AB develops a communication platform for the healthcare industry. The private company is based in Stockholm, Sweden.
1
| Private Company | Packaged Software | 1 |
Attgeno AB
 Attgeno AB Pharmaceuticals: MajorHealth Technology ATTGENO AB develops, manufactures, and trades pharmaceutical drugs and electronic apparatus. Its product, Supernitro, is a vasodilator indicated for the treatment of acute pulmonary hypertension associated with major cardiac surgery. The company is headquartered in Stockholm, Sweden.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Mordin AB
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Gunnar Magnus Modee Persson via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| CELGENE | Biotechnology | Founder Chief Executive Officer Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Investor Relations Contact | |
| ACTIVE BIOTECH AB | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Investor Relations Contact Corporate Officer/Principal | |
| MEDA AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
| BIOTAGE AB | Medical Specialties | Corporate Officer/Principal Director/Board Member Director of Finance/CFO | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
| RAYSEARCH LABORATORIES AB | Packaged Software | Chairman Director of Finance/CFO | |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
| University of Medicine & Dentistry of New Jersey | College/University | Chairman Corporate Officer/Principal Director/Board Member | |
| University of Toronto | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
| Copenhagen Business School | College/University | Graduate Degree Director/Board Member | |
| Stockholm School of Economics | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Graduate Degree | |
| University of Uppsala | College/University | Doctorate Degree Doctorate Degree Masters Business Admin Corporate Officer/Principal Doctorate Degree | |
| University of Stockholm | College/University | Doctorate Degree Director/Board Member Undergraduate Degree Undergraduate Degree | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Founder Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| Royal Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree | |
| University of Lund | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
| University of Copenhagen | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| University of Lausanne | College/University | Corporate Officer/Principal Masters Business Admin | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| BIOARCTIC AB | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Director/Board Member | |
Isogenica Ltd.
 Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Protein Technologies, Inc.
 Protein Technologies, Inc. Medical SpecialtiesHealth Technology Protein Technologies, Inc. engages in the design, manufacture and supply of solid phase synthesizers. The company was founded in 1985 and is headquartered in Tucson, AZ. | Medical Specialties | Director/Board Member President | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
Karolinska University Hospital
 Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Contera Pharma ApS
 Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Founder Director/Board Member | |
| CALMARK SWEDEN AB | Medical Specialties | Director/Board Member Director/Board Member | |
Acesion Pharma ApS
 Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Allarity Therapeutics Europe ApS
 Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Founder Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Undergraduate Degree | |
Glionova AB
 Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director/Board Member | |
| CORLINE BIOMEDICAL AB | Medical Specialties | Director/Board Member Director/Board Member | |
| PREBONA AB | Household/Personal Care | Chairman Director/Board Member | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
Gyros Protein Technologies AB
 Gyros Protein Technologies AB Medical SpecialtiesHealth Technology Gyros Protein Technologies AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. It provides sample preparation, synthesis and bioanalytical tools for biotherapeutics discovery, development and bioprocessing. The company was founded in March 2016 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Director/Board Member Chairman | |
| GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| ADHERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer |
Statistics
International
| Sweden | 28 |
| United States | 10 |
| Denmark | 9 |
| United Kingdom | 3 |
| Canada | 2 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 13 |
| Commercial Services | 5 |
| Technology Services | 2 |
| Health Services | 2 |
Operational
| Director/Board Member | 646 |
| Corporate Officer/Principal | 243 |
| Chairman | 158 |
| Independent Dir/Board Member | 128 |
| Chief Executive Officer | 119 |
Most connected contacts
| Insiders | |
|---|---|
| Björn Ingemar Odlander | 53 |
| Carola Elisabet Lemne | 47 |
| Eva Cecila Marlow | 40 |
| Søren Lemonius | 39 |
| Garry Neil | 38 |
| Peter Sjöstrand | 35 |
| Johan Rutger Christenson | 35 |
| Isaac Blech | 32 |
| Sol Barer | 32 |
| Peter Buhl Jensen | 32 |
| Hans Lennart Rudolf Wigzell | 30 |
| Joseph deBethizy | 29 |
| Nanna Liebach Lüneborg | 29 |
| David J. Parker | 29 |
| Sven Arne Andréasson | 24 |
- Stock Market
- Insiders
- Gunnar Magnus Modee Persson
- Company connections
